Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iTeos Therapeutics, Inc. - Common Stock (NQ:ITOS)

10.15 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iTeos Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
7 Top-Rated Biotech Stocks to Buy for Q2 ↗
In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill. 
Via InvestorPlace
News headline image
Children's Place And 2 Other Stocks Bought By Insiders ↗
Although US stock futures traded higher this morning on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
UBS lifted the price target on Pfizer Inc. (NYSE:PFE 
Via Benzinga
News headline image
iTeos Posts New Preclinical Data For Anti-TIGIT Antibody At ASH 2021 ↗
ITeos Therapeutics Inc (NASDAQ: ITOS) posted new preclinical data for its anti-TIGIT monoclonal antibody, EOS-448, at the American Society of Hematology (ASH)... 
Via Benzinga
Why iTeos Therapeutics Shares Are Surging Today ↗
iTeos Therapeutics Inc (NASDAQ:ITOS) shares are trading hi... 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2021 ↗
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as... 
Via Benzinga
News headline image
Why iTeos Therapeutics Stock Soared Today ↗
The biotech struck a potential $2 billion deal with a pharmaceutical giant. 
Via The Motley Fool
News headline image
Mid-Afternoon Market Update: Dow Tumbles 250 Points; Enochian Biosciences Shares Spike Higher ↗
Toward the end of trading Monday, the Dow traded down 0.74% to 34,225.89 while the NASDAQ rose 0.45% to 14,132.55. The S&P also fell, dropping 0.27% to 4,236.03. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 111.41% to $39.26 during Monday's regular session. As of 12:30 EST, this security is trading at a... 
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Rises Over 50 Points; Washington Prime Group Shares Plunge ↗
Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mostly Lower; Accenture To Acquire German Engineering Company ↗
Following the market opening Monday, the Dow traded down 0.43% to 34,332.41 while the NASDAQ rose 0.24% to 14,102.61. The S&P also fell, dropping 0.20% to 4,238.80. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Enochian BioSciences (NASDAQ:ENOB) stock increased by 147.84% to $10.93 during Monday's pre-market session. The company's market cap stands at $522.4... 
Via Benzinga
News headline image
iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK ↗
iTeos Therapeutics (NASDAQ: ITOS) and GlaxoSmithKline plc (NYSE: GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2021 ↗
Upgrades Atlantic Equities upgraded the previous rating for Under Armour Inc (NYSE:UAA) from Underweight to Neutral. Under Armour earned $0.16 in the first quarter. The... 
Via Benzinga
News headline image
Short Interest Through the End of March ↗
ln aggregate for Russell 3,000 stocks, short interest as a percent of equity float is little changed versus where it stood in mid-March. But on an industry basis, there have been some large moves. 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.